Chemed Total Non-Cash Items 2010-2025 | CHE

Chemed annual/quarterly total non-cash items history and growth rate from 2010 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Chemed total non-cash items for the quarter ending March 31, 2025 were $0.013B, a 53.02% decline year-over-year.
  • Chemed total non-cash items for the twelve months ending March 31, 2025 were $0.255B, a 3.2% increase year-over-year.
  • Chemed annual total non-cash items for 2024 were $0.106B, a 9.69% increase from 2023.
  • Chemed annual total non-cash items for 2023 were $0.096B, a 2.65% increase from 2022.
  • Chemed annual total non-cash items for 2022 were $0.094B, a 43.04% increase from 2021.
Chemed Annual Total Non-Cash Items
(Millions of US $)
2024 $106
2023 $96
2022 $94
2021 $66
2020 $125
2019 $72
2018 $64
2017 $77
2016 $59
2015 $69
2014 $65
2013 $55
2012 $54
2011 $65
2010 $55
2009 $64
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.483B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00